Sigma Aldrich Posts Flat Q2 Revenue As Profit Rises 12 Percent | GenomeWeb
NEW YORK (GenomeWeb News) — Sigma Aldrich yesterday reported flat second-quarter revenue growth as net income grew 12 percent.
 
Total revenues for the three months ended June 30 increased to $449 million from $444 million year over year.
 
Net income grew 12 percent to $70.3 million from $62.5 million year over year, the company said
 
Research and development expenses increased 2 percent to $13.4 million from $13.1 in the prior-year period.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.